AstraZeneca CEO pay package rise gets narrow investor approval By Reuters
By Pushkala Aripaka and Ludwig Burger (Reuters) -AstraZeneca shareholders narrowly approved Chief Executive Pascal Soriot's proposed pay package on Tuesday, after investor advisory groups said its rewards were excessive. At its annual investor meeting, 60.19% of votes cast were in favour of approving the new remuneration policy, AstraZeneca (NASDAQ:AZN) said, acknowledging that a "meaningful proportion" were against. Shares in London-listed AstraZeneca were down 1.3% to 7,615 pence at 1404 GMT after the vote, which comes as the drugmaker faces a second European Union legal move over delayed deliveries of its COVID-19 vaccine and concerns over...
Подробнее